Abstract
Introduction
Cancers of unknown primary site (CUPs) consist of a clinical entity which accounts for 3–5% of all solid tumor patients. They are metastatic solid tumors whose fundamental characteristic is the absence of identifiable site of the primary tumor.
Case Report
We report the case of a completely asymptomatic 34-year-old man with a palpated huge mass found incidentally in the left abdomen. All the investigations were normal. During the operation, a large mass was identified 2 cm below the left renal artery which was displacing and encompassing the great retroperitoneal vessels and the left ureter. A complete resection of the mass was performed while the histological examination revealed a solitary retroperitoneal lymph node categorized as metastatic adenocarcinoma of unknown primary site.
Conclusion
It is essential to assess the high incidence of patients with cancer who present with CUP. Early surgical excision of the metastatic lesion followed by adjuvant combination chemotherapy should be considered for patients with only a single site of malignancy.
References
Levi F, Te VC, Erler G, Randimbison L, La Vecchia C. Epidemiology of unknown primary tumors. Eur J Cancer. 2002;38:1810–1812.
van de Wouw AJ, Janssen-Heijnen MLG, Coebergh JWW, Hillen HF. Epidemiology of unknown primary tumors; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984–1992. Eur J Cancer. 2002;38:409–413.
Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer. 2003;39:1990–2005.
Casciato DA. Metastases of unknown origin. In: Casciato DA, editor. Manual of clinical oncology. 5th ed. Philadelphia: Lippincott; 2004. p. 402–413.
Pentheroudakis G, Briasoulis E, Pavlidis N. Cancer of unknown primary site: missing primary or missing biology? Oncologist. 2007;12:418–425.
Briasoulis E, Pavlidis N. Cancer of unknown primary origin. Oncologist. 1997;2:142–152.
Greco FA, Hainsworth JD. Cancer of unknown primary site. In: DeVita TV, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 4th ed. Philadelphia: Lippincott; 1997. p. 2423–2443.
Bugat R, Bataillard A, Lesimple T, Voigt JJ, Culine S, Lortholary A, et al. Summary of the standards, options, and recommendations for the management of patients with carcinoma of unknown primary site (2002). Br J Cancer. 2003;89(Suppl 1):s59–s66.
Lembersky BC, Thomas LC. Metastases of unknown primary site. Med Clin North Am. 1996;80:153–171.
Briasoulis E, Kalofonos H, Bafaloukos D, Samantas E, Fountzilas G, Xiros N, et al. Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study. J Clin Oncol. 2000;18:3101–3107.
Culine S, Fabbro M, Ychou M, Romleu G, Cupissol D, Pujol H. Alternative bimonthly cycles of doxorubicin, cyclophosphamide, and etoposide, cisplatin with hematopoietic growth factor support in patients with carcinoma of unknown primary site. Cancer. 2002;94:840–846.
Greco FA, Gray J, Burris HA III, Erland JB, Morrissey LH, Hainsworth JD. Taxane-based chemotherapy for patients with carcinoma of unknown primary site. Cancer J. 2001;7:203–212.
Saghatchian M, Fizazi K, Borel C, Ducreux M, Ruffie P, Le Chevalier T, et al. Carcinoma of an unknown primary site: a chemotherapy strategy based on histological differentiation—results of a prospective study. Ann Oncol. 2001;12:535–540.
Piga A, Nortilli R, Cetto GL, Cardarelli N, Fedeli SL, Fiorentini G, et al. Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site. Br J Cancer. 2004;90:1898–1904.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stakia, P., Lagos, P., Gourgiotis, S. et al. Large Mass Affecting Retroperitoneal Great Vessels: A Rare Presentation of A Cancer of Unknown Primary with Diagnostic Dilemma and Challenged Surgical Intervention. J Gastrointest Canc 40, 55–58 (2009). https://doi.org/10.1007/s12029-009-9076-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-009-9076-9